Heavy Traffic
StoryTK01
StoryTK02__Turkey > Syria > Iraq__ On numerous occasions, Conflict Armament Research (CAR) has discovered Turkish weapons, ammunition, and explosive materials among ISIS forces in Iraq and Syria. The organization also believes that most of the chemicals that ISIS uses to make explosives are purchased on the civilian market in Turkey.
StoryTK03__Bulgaria > Serbia > Burundi > Iraq__ Iraqi authorities recovered Bulgarian-made rockets from ISIS forces on two separate occasions. Both appeared to be a part of a shipment that passed through Serbia and Burundi before arriving in Iraq. (Bulgarian weapons purchased by Saudi Arabia have also been smuggled into Syria, most likely through Jordan.)
StoryTK04__China > South Sudan > Syria__ Chinese-manufactured rifles popular among rebels in South Sudan were recovered from ISIS during the siege of Kobani, Syria, which began in September 2014 and ended in January 2015.
StoryTK05__Belgium > Libya > Syria__ Belgian-manufactured ammunition that was originally sold to Gadhafi's Libya in the 1980s has reemerged decades later in ISIS strongholds.
StoryTK06__Romania > US > Iraq__ CAR has tracked numerous shipments of Romanian rockets that were sold to the US and later recovered from ISIS forces. (Spleeters says CAR is not sure whether these shipments were ever physically delivered to the US or if they were sent directly elsewhere.)
There’s Finally Video of a Great White Shark in the Mediterranean
A recent video of a great white shark in the Mediterranean Sea offers the possibility of deriving valuable information for conservation strategies.
Marta Musso
GM Wants Your Electric Car to Power Your House—and Your Neighborhood
The automaker today is turning on vehicle-to-grid charging for its GM Energy customers. Will people actually use it?
Aarian Marshall
The Top New Features Coming to MacOS 27 Golden Gate
Apple has announced the latest version of macOS. It’s all about the reintroduction of Siri, which is now accessible from anywhere on the Mac desktop.
Luke Larsen
The Top New Features in Apple’s iOS 27 and iPadOS 27
Apple took the wraps off iOS 27 at its WWDC event, and the iPhone update is chock-full of smart upgrades, with a big focus on improvements to Siri.
Julian Chokkattu
Anthropic Offers Mythos Upgrade for Cyber Partners and a ‘Safe’ Version for the Rest of You
Anthropic is releasing Claude Mythos 5 to trusted organizations and Claude Fable 5 to the public, a version it says can’t be used for cyberattacks.
Maxwell Zeff
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
Isabella Ward
The Rivian R2 Is the Rivian for the Masses
With a competitive price, winning design, and better performance than the R1, Rivian could be set to break into the big leagues. Just make sure you get the right model with the right tech.
Jeremy White
The Best Smart Bird Feeders for Backyard Birding
These bird feeders come with cameras and connected apps to let you see and learn about the birds in your neighborhood.
Kat Merck
Amazon’s Ember Artline Makes Art TVs More Accessible
The affordable Artline doubles as a design piece and comes close to outshining the reigning champion of art TVs, the Samsung Frame Pro.
John Brandon
The Untold Story of the Google Buses That Took Over San Francisco
A decade ago, commuter buses attracted big protests in San Francisco. Years later, the city is still feeling the repercussions.
Jonathan Weber
Alex Vindman Survived Trump’s Retaliation Machine. Now He’s Running for Senate
In 2019, Alex Vindman testified during President Trump’s first impeachment trial–a decision that ended his military career. Now he wants to challenge the president from the halls of Congress.
Katie Drummond
Anguished Parents, Crying Doctors: Life Amid Utah’s Measles Outbreak
The state’s outbreak means adapting to America’s new reality, in which vaccine-preventable diseases become common again.
Amy Maxmen, KFF Health News